Biomimetic mineralized composite bone filling material with plastic shape as well as preparation method and application of biomimetic mineralized composite bone filling material
Through the preparation of decalcified cancellous bone and bionic mineralization technology, the bone induction and mineralization of bone fillers are solved, and morphological plasticity and rapid bone repair are achieved, providing an efficient bone filler material Solution.
Patent Information
- Application Number
- CN202411036841.8
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-07-31
- Publication Date
- 2024-11-15
- Estimated Expiration
- 2044-07-31
AI Technical Summary
The existing bone filling materials lack osteoinductivity, poor mineralization effect, poor shaping, difficult operation, and lack calcium and phosphorus required for bone formation, resulting in slow repair of bone defects.
Through the preparation of decalcified cancellous bone and bionic mineralization technology, a bionic mineralized composite bone filler with morphological plasticity and injectability was prepared, and in situ mineralization was used to form nano-scale hydroxyl groups by phosphorylation treatment and mineralization solution. Apatite coating simulates natural bone mineralization and promotes new bone formation.
It achieves efficient osteoinduction and rapid bone repair. The material has good biocompatibility and biodegradation performance. It is simple to operate and low cost. It can complete biodegradation within 3 months and coordinate the bone formation time.
Smart Images

Figure CN118949136A_ABST
Abstract
Description
Technical Field
[0001] The present invention belongs to the technical field of preparation of bone filling materials, and in particular relates to a morphologically plastic bionic mineralized composite bone filling material and a preparation method and application thereof. Background Art
[0002] During dental implant surgery, after tooth extraction, the alveolar ridge undergoes progressive and irreversible absorption, often resulting in problems such as decreased bone mass and low alveolar ridge, which makes denture restoration or implant placement difficult and seriously affects the patient's aesthetics. A large number of clinical studies have shown that the use of bone filling materials to preserve extraction sites can effectively reduce the absorption of the alveolar ridge and provide sufficient bone mass and good bone quality for later implant restoration. This is also the most commonly used treatment method. From a material perspective, its products are mainly divided into four categories: ① Natural bio-derived materials, such as decalcified bone matrix (allogeneic bone, xenogeneic bone), chitosan, alginate, etc.; ② Artificially synthesized inorganic materials, such as hydroxyapatite (HA), tricalcium phosphate (TCP), and bioactive glass; ③ Artificially synthesized organic materials, such as polylactic acid and its copolymers; ④ Artificially synthesized composite materials, such as collagen-TCP and other organic-inorganic composites.
[0003] Generally speaking, an ideal bone filling material needs to have the following characteristics: ① osteoconductivity, that is, the scaffolding effect of "soil", which is conducive to the growth of capillaries and bone cells into the material; ② osteoinduction, that is, the nutritional effect of "nutrients", which can promote the differentiation of mesenchymal cells into osteoblasts. Although decalcified bone matrix has been widely proven to have both clear osteoinduction and osteoconduction effects, it is still difficult to use in actual clinical practice: ① On the one hand, the particles of decalcified bone matrix are relatively loose, that is, they cannot be accurately filled in the narrow extraction socket, nor can they stay stably in the extraction socket, and are easily washed away by blood or flushing operations; ② If preformed in advance, the sample cannot be implanted in the extraction socket if it is too large, and the dead space caused by the sample if it is too small will cause alveolar bone defects; ③ Lack of calcium and phosphorus required for bone formation, the bone formation rate is slow.
[0004] Some studies have begun to focus on how to treat cancellous bone in a milder way, making it non-immunogenic while retaining osteoinductivity, and in situ mineralization of hydroxyapatite coatings that are more consistent with the structural components of human bones, so that the degradation of bone filling materials and the release of calcium and phosphorus become controllable. Existing products are made by combining bone morphogenetic protein-2 with materials such as hydroxyapatite, but they are expensive, and their release rate is difficult to control, which can easily lead to the risk of over-repair or incomplete repair.
[0005] For example, Chinese patent document CN116712613A provides a bone filling material, which is prepared by cross-linking raw material A (hyaluronic acid or chitosan) with raw material A through a cross-linking agent, and covalent cross-linking between collagen and collagen; hydroxyapatite is deposited on collagen by physical deposition to obtain a bone filling material. It has a material composition and microscopic and macroscopic structure consistent with natural periosteum, and has good mechanical properties and biodegradability. However, due to simple physical mixing, it is impossible to achieve uniform distribution of inorganic phase and organic phase.
[0006] Chinese patent document CN105169482A provides a dental bone substitute material, which is a porous scaffold of fetal bovine cancellous bone prepared by chemical treatment and calcination process, and the surface treatment forms calcium phosphate mineralization crystals. Compared with bone substitute materials from other types of animals, it has a shorter in vivo metabolism time and is more in line with the needs of clinical bone grafting. However, due to the use of calcined bone as a carrier, it lacks the organic components of natural bone tissue and has no bone induction.
[0007] Chinese patent document CN1106861C provides a nano-phase calcium phosphate / collagen / polylactic acid bone composite porous material, which relates to a method for in-situ mineralization of collagen, and its composition is similar to human bone. However, its carrier is purified collagen, which has no bone induction, and it is difficult to arbitrarily adjust the degree of mineralization.
[0008] Chinese patent document CN109276761B provides a bone repair material containing rh-BMP2 and phosphate, which uses chitosan as a sustained-release carrier to achieve a sustained and effective working concentration of BMP-2. However, it lacks a bone tissue collagen scaffold structure, cannot reproduce in situ biomimetic mineralization, and the release rate of inorganic components is uncontrollable.
[0009] In addition, Chinese patent document CN 109381745 B provides a collagen coral hydroxyapatite composite bone filling scaffold material, which can not only effectively avoid the risk of disease transmission in natural tissue extraction, but also has a natural pore structure that synthetic hydroxyapatite does not have, solving the disadvantage that coral hydroxyapatite particles themselves are difficult to shape. However, this bone filling scaffold material lacks the organic components of natural bone tissue, has no bone inductivity, and its pre-shaping is difficult to adapt to complex bone defect wounds.
[0010] Chinese patent document CN 114366854 B provides a silicone rhinoplasty material composited with decalcified bone matrix, but the material lacks the inorganic components of natural bone tissue and only relies on silicone for support, without any new bone formation effect.
[0011] Therefore, on the one hand, how to solve the problem of the lack of osteoinductivity of existing bone filling materials, so that the bone filling materials retain sufficient active substances and have high osteoinductivity; on the other hand, how to achieve better mineralization effect and faster repair of bone defects; at the same time, it is also necessary to solve the problems of common decalcified cancellous bone products lacking calcium and phosphorus required for bone formation, poor plasticity of bone filling materials, and difficulty in surgical operations, which have become technical problems that need to be solved urgently. Summary of the invention
[0012] The present invention is to solve the above technical problems, thereby providing a morphologically plastic bionic mineralized composite bone filling material and its preparation method and application. The technical purpose of the present invention is to provide a bone filling material with high decalcification efficiency, high content of active ingredients, in-situ mineralization, good mineralization effect, morphological plasticity, injectability, and convenient operation, so as to solve the problems of existing bone filling materials such as low content of active ingredients, lack of bone inductivity, poor mineralization effect, poor plasticity, and difficulty in operation.
[0013] In order to achieve the above technical objectives, the technical solution adopted by the present invention is as follows:
[0014] The present invention first provides a method for preparing a morphologically plastic biomimetic mineralized composite bone filling material, comprising the following steps:
[0015] 1. Preparation of decalcified cancellous bone
[0016] (1) The cancellous bone is crushed into bone powder with a particle size of 0.3 to 0.8 mm, and then added to an EDTA solution at a solid-liquid ratio of 1:5 to 1:30 w / v, and decalcified at room temperature for 4 to 16 hours under shaking;
[0017] (2) adding the cancellous bone treated in step (1) to a peracetic acid solution at a solid-liquid ratio of 1:4 w / v, and shaking at room temperature for 2 hours;
[0018] (3) adding the cancellous bone treated in step (2) to isopropanol at a solid-liquid ratio of 1:5 to 1:10 w / v, and degreasing by shaking at room temperature for 24 hours;
[0019] (4) adding the cancellous bone treated in step (3) to a 1-4 wt% sodium deoxycholate solution at a solid-liquid ratio of 1:5-1:10 w / v, and shaking at room temperature to decellularize for 8-24 hours to prepare decalcified cancellous bone;
[0020] (II) Preparation of mineralized decalcified cancellous bone
[0021] (5) adding the decalcified cancellous bone obtained in step (4) to a 2-3 wt % sodium trimetaphosphate solution at a material-liquid ratio of 1:5-1:10 w / v, shaking at room temperature for 1 hour, and performing phosphorylation treatment;
[0022] (6) immersing the phosphorylated decalcified cancellous bone in a mineralizing solution at a material-liquid ratio of 1:200 to 1:500 w / v, and performing biomimetic mineralization at 37° C. for 1 to 5 days with shaking, wherein the mineralizing solution comprises: 100 to 160 mM sodium chloride, 2 to 4 mM dipotassium hydrogen phosphate, 3 to 5 mM magnesium chloride, 35 to 40 mM 4-hydroxyethylpiperazineethanesulfonic acid, 15 to 22 mM sodium bicarbonate, 6 to 9 mM calcium chloride, and a pH value of 6.5 to 7.0, to prepare mineralized decalcified cancellous bone;
[0023] (III) Preparation of thermosensitive cancellous bone hydrogel
[0024] (7) taking the decalcified cancellous bone obtained in step (4), adding it to a 0.1 wt % porcine pepsin solution at a solid-liquid ratio of 1:100 w / v, and stirring at 4° C. for 24 to 48 hours;
[0025] (8) adding alkali to the product obtained in step (7) to adjust the pH to 7.2-7.4, then adding PBS buffer to adjust the solution ionic strength to 0.5-1.5×PBS, and then adding 1×PBS to adjust the concentration of the hydrogel solution to 0.4-0.8 wt %;
[0026] (IV) Preparation of biomimetic mineralized composite bone filling materials
[0027] (9) Take the mineralized decalcified cancellous bone obtained in step (6), add it to the hydrogel solution obtained in step (8) at a material-liquid ratio of 1 to 3:1 w / v, and stir at 4° C. for 24 hours to obtain a biomimetic mineralized composite bone filling material.
[0028] The above-mentioned preparation method provided by the present invention first prepares a mineralized decalcified cancellous bone material having a similar structure, composition and micromorphology to autologous bone through biomimetic mineralization technology. The material is treated with phosphorylation to increase the nucleation sites of decalcified cancellous bone, which shortens the total mineralization time on the one hand and makes the mineralization process more stable on the other hand. Simulating natural bone mineralization, in situ mineralization forms an inorganic salt coating on the decalcified cancellous bone, which has the function of better promoting the formation of new bone and guiding bone regeneration. Through the phosphorylation and mineralization treatment of the present invention, the problem that the existing bone filling materials usually have a low active ingredient content and a long degradation cycle is well solved. This method mineralizes nano-hydroxyapatite on a natural decalcified cancellous bone scaffold for the first time, removes immunogenicity, retains active ingredients well, and can regulate cell signal transduction, so that it can be self-regulated by the body to release calcium and phosphorus and efficiently form bones.
[0029] The bone filling material prepared by the method of the present invention is obtained by taking cancellous bone from animal femur, pre-processing, decalcification, virus inactivation, defatting, decellularization, and biomimetic mineralization. It is based on the porous three-dimensional collagen scaffold of natural bones, and is mineralized into a material with nano-hydroxyapatite as the main component, which well retains bone inductivity. It can not only provide a three-dimensional scaffold structure for regenerated tissue cells, but also has the functions of regulating the behavior of regenerated cells (including cell morphology, adhesion, proliferation, migration, differentiation and apoptosis), and has good biocompatibility and biodegradability. In addition, its preparation process is simple, low-cost, short-time, and the degree of mineralization of the final product can be regulated.
[0030] On this basis, the present invention further compounds the mineralized decalcified cancellous bone with the thermosensitive cancellous bone hydrogel to prepare a morphologically plastic bionic mineralized composite bone filling material. The composite material uses decalcified cancellous bone as a carrier, undergoes in-situ mineralization in a mineralizing solution to obtain a bone filling material, and at the same time, the bone filling material is fully mixed with the thermosensitive hydrogel derived from the decalcified cancellous bone to form a composite bone filling material, which has morphological plasticity and injectability, and the operation method is simple. The method solves the problems of common decalcified cancellous bone products lacking calcium and phosphorus required for bone formation, as well as poor plasticity and difficulty in surgical operation.
[0031] The decalcified cancellous bone after in situ mineralization of the present invention has the pore structure of natural bone and nano-scale hydroxyapatite, and is biodegradable, biocompatible and osteoinductive, and is more conducive to the growth and proliferation of blood vessels and cells, achieving the advantage of faster repair speed in clinical practice.
[0032] The present invention creatively adopts a collagen scaffold with a natural bone porous three-dimensional structure as an organic component, and maintains the natural porosity of cancellous bone, and the pore size is suitable for the growth of bone tissue and vascular tissue. Therefore, it can not only provide a three-dimensional scaffold structure for regenerated tissue cells, but also contains abundant non-collagen signal macromolecules and bone-inducing protein components, so that the bone filling material has excellent osteogenic properties. The surface nano-scale hydroxyapatite coating releases calcium, phosphorus and active substances with the self-regulation of the human body. After inducing osteogenesis at the defect site, the exposed collagen scaffold can be degraded relatively quickly and provide the required substances for the osteogenesis site. Therefore, the bone filling material also has excellent degradation properties that can be adjusted according to the needs of the human body.
[0033] Furthermore, the concentration of the EDTA solution in step (1) is 10 wt %; as a preferred solution, the pH value of the EDTA solution is 7.4.
[0034] Furthermore, the concentration of the peracetic acid solution in step (2) is 0.3 wt %.
[0035] Furthermore, the pH of the sodium deoxycholate solution in step (4) is 8.
[0036] Furthermore, the pH of the sodium trimetaphosphate solution in step (5) is 10.
[0037] Furthermore, in step (6), during the oscillating biomimetic mineralization process, the mineralization liquid is replaced every 24 hours.
[0038] Furthermore, in steps (1) to (6), the cancellous bone after each treatment is cleaned, and the cleaning steps are: pouring the treated cancellous bone into purified water at a solid-liquid ratio of 1:10 to 1:20 w / v, shaking and cleaning at room temperature for 1 hour, and changing the liquid every 5 minutes.
[0039] Furthermore, the pH of the porcine pepsin solution in step (7) is 2-3.
[0040] Furthermore, the operation of adjusting the pH and ionic strength in step (8) is: adding 0.1 M sodium hydroxide dropwise to the resultant treated in step (7) under stirring at 4° C. until the pH range is 7.2 to 7.4, and then slowly adding 10×PBS buffer to the resultant to adjust the solution ionic strength to 0.5 to 1.5×PBS.
[0041] The beneficial effects of the present invention are as follows:
[0042] (1) The composite bone filling material prepared by the method of the present invention has an organic phase ratio of 15%-25wt%, an inorganic phase ratio of 35%-55wt% (the remaining components are water), and has a composition and structure similar to natural bone;
[0043] (2) The composite bone filling material prepared by the present invention contains abundant bone morphogenetic protein BMP-2 and other osteogenic active factors and has excellent osteoinductivity;
[0044] (3) The composite bone filling material of the present invention eliminates immunogenicity, retains active ingredients well, and can regulate cell signal transduction, so that it can be self-regulated by the body to release calcium and phosphorus and efficiently form bones;
[0045] (4) The composite bone filling material of the present invention has excellent plasticity and injectability;
[0046] (5) The composite bone filling material of the present invention can be used for the rapid repair of oral and maxillofacial bone defects and can be biodegraded within 3 months, which is consistent with the bone formation time. BRIEF DESCRIPTION OF THE DRAWINGS
[0047] Figure 1 This is a physical picture of a sample of mineralized cancellous bone filling material prepared in an embodiment of the present invention.
[0048] Figure 2 Scanning electron microscope images of the mineralized cancellous bone filling material prepared in accordance with an embodiment of the present invention (left: before mineralization; right: after mineralization).
[0049] Figure 3 This is an enlarged view of the inorganic phase of the mineralized cancellous bone filling material prepared in an embodiment of the present invention. Figure 4 This is the inorganic phase XRD result of the mineralized cancellous bone filling material prepared in the embodiment of the present invention (the surface coating phase component is hydroxyapatite).
[0050] Figure 5 Rabbit mandibles were obtained 8 weeks after modeling (left: Bio-Oss; right: example sample). Figure 6 X-rays of the rabbit mandible were taken 8 weeks after modeling (left: Bio-Oss; right: Example sample).
[0051] Figure 7 Rabbit mandibles were obtained 12 weeks after modeling (left: Bio-Oss; right: Example sample). Figure 8 This is the self-assembly process of thermosensitive cancellous bone hydrogel at 37°C (left: room temperature; right: after self-assembly at 37°C).
[0052] Fig. 9 This is the effect of the concentration of thermosensitive cancellous bone hydrogel on the self-assembly cross-linking time of the material.
[0053] Fig.10 The self-assembly and cross-linking of thermosensitive cancellous bone hydrogels with different ionic strengths.
[0054] Fig.11 It is the microstructure of thermosensitive cancellous bone hydrogel.
[0055] Fig.12 Calcium ion release of morphologically plastic biomimetic mineralized composite bone filling material (●: decalcified cancellous bone; ■: example sample).
[0056] Fig.13 The phosphate ion release of the morphologically plastic biomimetic mineralized composite bone filling material (●: decalcified cancellous bone; ■: example sample).
[0057] Fig.14 Immediately after implantation, two groups of products remained stable (left: Example sample; right: decalcified cancellous bone).
[0058] Fig.15 The X-ray results after 12 weeks of modeling (left: Example sample; right: decalcified cancellous bone). DETAILED DESCRIPTION
[0059] In order to make the purpose, technical scheme and advantages of the present invention clearer, the present invention is described in detail below in conjunction with the embodiments. It is necessary to point out that the following embodiments are only used to explain and illustrate the present invention and are not used to limit the present invention. Some non-essential improvements and adjustments made by those skilled in the art based on the above invention content still belong to the protection scope of the present invention.
[0060] Example 1
[0061] This embodiment provides a method for preparing a morphologically plastic biomimetic mineralized composite bone filling material, and the specific preparation steps are as follows:
[0062] 1. Preparation of decalcified cancellous bone
[0063] 1.1 Pretreatment: Take the whole femur, cut the cancellous bone at both ends of the femur with a bone cutter, and discard the cortical bone in the middle. Use a bone cutter to remove all the cortical bones on the outer circle of the bone block, leaving only the cancellous bone. Finally, use a bone cutter to cut the cancellous bone into bone particles. Take the bone particles and crush them, pour them into purified water at a material-liquid ratio of 1:10 (w / v), shake and wash at room temperature for 1 hour, change the liquid every 5 minutes, and sieve to obtain bone powder with a particle size of 0.3mm.
[0064] 1.2 Decalcification: Take the sample prepared in step 1.1, add 10wt% EDTA solution (pH~7.4) at a solid-liquid ratio of 1:5 (w / v), and decalcify at room temperature for 4 hours. After completion, pour purified water at a liquid ratio of 1:10 (w / v), shake and wash at room temperature for 1 hour, and change the liquid every 5 minutes.
[0065] 1.3 Virus inactivation: Take the sample prepared in step 1.2, add 0.3wt% peracetic acid solution at a material-liquid ratio of 1:4 (w / v), and shake at room temperature for 2 hours. After completion, pour purified water at a material-liquid ratio of 1:10 (w / v), shake and wash at room temperature for 1 hour, and change the solution every 5 minutes.
[0066] 1.4 Degreasing: Take the sample prepared in step 1.3, add isopropanol at a solid-liquid ratio of 1:5 (w / v), degrease at room temperature for 24 hours, and change the liquid every 8 hours. After the end, pour purified water at a solid-liquid ratio of 1:10 (w / v), wash at room temperature for 1 hour, and change the liquid every 5 minutes.
[0067] 1.5 Decellularization: Take the sample prepared in step 1.4, add 1wt% sodium deoxycholate solution (pH ~ 8) at a material-liquid ratio of 1:5 (w / v), and decellularize at room temperature for 8 hours. After completion, pour in normal saline at a material-liquid ratio of 1:10 (w / v), shake and wash at room temperature for 30 minutes, and change the solution every 5 minutes. Then pour in purified water at a material-liquid ratio of 1:10 (w / v), shake and wash at room temperature for 30 minutes, and change the solution every 5 minutes to obtain decalcified cancellous bone.
[0068] (II) Preparation of mineralized decalcified cancellous bone
[0069] 2.1 Phosphorylation treatment: Take the decalcified cancellous bone prepared in method (I), add 2wt% sodium trimetaphosphate (pH ~ 10) at a material-liquid ratio of 1:5 (w / v), and shake at room temperature for 1 hour. After completion, pour purified water at a material-liquid ratio of 1:10 (w / v), shake and wash at room temperature for 1 hour, and change the liquid every 5 minutes.
[0070] 2.2 Preparation of biomimetic mineralization solution: Weigh sodium chloride, potassium dihydrogen phosphate, and magnesium chloride in purified water. After they are completely dissolved, add appropriate amounts of 4-hydroxyethylpiperazineethanesulfonic acid and sodium bicarbonate to maintain the pH of the system, and then add calcium chloride and stir until the solution is clear. The final concentration of the solution is 100mM sodium chloride, 2mM potassium dihydrogen phosphate, 3mM magnesium chloride, 35mM 4-hydroxyethylpiperazineethanesulfonic acid, 15mM sodium bicarbonate, 6mM calcium chloride, and the pH value is 6.5.
[0071] 2.3 Bionic mineralization: Take the sample phosphorylated in step 2.1, add the mineralization solution prepared in step 2.2 at a material-liquid ratio of 1:200, shake at 37°C for biomimetic mineralization, and change the solution every 24 hours. After completion, pour purified water at a material-liquid ratio of 1:10 (w / v), shake and wash at room temperature for 1 hour, and change the solution every 5 minutes.
[0072] (III) Preparation of thermosensitive cancellous bone hydrogel
[0073] 3.1 Digestion: Take decalcified cancellous bone, add 0.1wt% porcine pepsin solution (pH 2-3) at a solid-liquid ratio of 1:100 (w / v), and stir at 4°C for 24-48 hours until it becomes a translucent liquid with no obvious particles visible to the naked eye.
[0074] 3.2 Neutralization: Take the sample from step 3.1, keep stirring at 4°C, and add 0.1 M sodium hydroxide dropwise until the pH range is 7.2-7.4.
[0075] 3.3 Adjusting ionic strength: Take the sample from step 3.2, keep stirring at 4°C, slowly add 10× phosphate buffer (PBS) to adjust the solution ionic strength to 0.5-1.5×PBS, then add 1×PBS to adjust the hydrogel concentration to 0.4-0.8wt%.
[0076] (IV) Preparation of composite bone filling materials
[0077] Take the sample from step 2.3, add the sample from step 3.3 according to a material-liquid ratio of 1 to 3:1 (w / v), stir at 4° C. for 24 hours, and fill into a prefilled syringe to obtain an injectable composite bone filling material.
[0078] Example 2
[0079] The method according to Example 1 is different in that:
[0080] In step 1.1, bone powder with a particle size range of 0.4 to 0.6 mm was prepared at a material-liquid ratio of 1:12 (w / v);
[0081] In step 1.2, 10 wt% EDTA solution was added at a material-liquid ratio of 1:10 (w / v), and decalcification was performed at room temperature with shaking for 10 hours;
[0082] In step 1.4, isopropanol was added at a material-liquid ratio of 1:8 (w / v);
[0083] In step 1.5, 2 wt% sodium deoxycholate solution was added at a material-liquid ratio of 1:8 (w / v), and the cells were removed by shaking at room temperature for 12 hours; physiological saline was poured in at a material-liquid ratio of 1:15 (w / v);
[0084] In step 2.1, 2.5 wt% sodium trimetaphosphate is added at a material-liquid ratio of 1:8 (w / v);
[0085] The final concentration of the mineralization solution in step 2.2 is 120 mM sodium chloride, 3 mM potassium hydrogen phosphate, 4 mM magnesium chloride, 38 mM 4-hydroxyethylpiperazineethanesulfonic acid, 18 mM sodium bicarbonate, 8 mM calcium chloride, and the pH value is 6.8;
[0086] In step 2.3, the mineralization solution is added at a material-liquid ratio of 1:300 (w / v);
[0087] In all the above steps, purified water was added to the treated cancellous bone at a solid-liquid ratio of 1:20 (w / v), and the bone was washed with shaking at room temperature for 1 hour, with the liquid being changed every 5 minutes.
[0088] In step 3.1, stir at 4°C for 48 hours until the mixture becomes a translucent liquid with no obvious particles visible to the naked eye.
[0089] In step 3.3, the concentration of the hydrogel solution was adjusted to 0.8 wt %.
[0090] In step (iv), the addition is performed at a solid-liquid ratio of 3:1 (w / v).
[0091] Example 3
[0092] The method according to Example 1 is different in that:
[0093] In step 1.1, the bone powder with a particle size of 0.8 mm was taken at a material-liquid ratio of 1:18 (w / v);
[0094] In step 1.2, 10 wt% EDTA solution was added at a solid-liquid ratio of 1:30 (w / v), and decalcification was performed by shaking at room temperature for 16 hours;
[0095] In step 1.4, isopropanol was added at a material-liquid ratio of 1:10 (w / v);
[0096] In step 1.5, 4 wt% sodium deoxycholate solution was added at a material-liquid ratio of 1:10 (w / v), and the cells were removed by shaking at room temperature for 24 hours; physiological saline was poured in at a material-liquid ratio of 1:20 (w / v);
[0097] In step 2.1, 3 wt% sodium trimetaphosphate is added at a material-liquid ratio of 1:10 (w / v);
[0098] The final concentrations of the mineralization solution in step 2.2 are 160 mM sodium chloride, 4 mM potassium hydrogen phosphate, 5 mM magnesium chloride, 40 mM 4-hydroxyethylpiperazineethanesulfonic acid, 22 mM sodium bicarbonate, 9 mM calcium chloride, and a pH value of 7.0;
[0099] In step 2.3, the mineralization solution was added at a material-liquid ratio of 1:500 (w / v).
[0100] In all the above steps, purified water was added to the treated cancellous bone at a solid-liquid ratio of 1:20 (w / v), and the bone was washed with shaking at room temperature for 1 hour, with the liquid being changed every 5 minutes.
[0101] In step 3.1, stir at 4°C for 36 hours until the mixture becomes a translucent liquid with no obvious particles visible to the naked eye.
[0102] In step 3.3, the concentration of the hydrogel solution was adjusted to 0.6 wt %.
[0103] In step (iv), the addition is performed at a solid-liquid ratio of 2:1 (w / v).
[0104] Performance Test:
[0105] After testing, the composite bone filling materials prepared by the above methods of Examples 1-3 of the present invention have the following characteristics:
[0106] (1) The organic phase in the composite bone filling material accounts for 15%-25wt%, and the inorganic phase accounts for 35%-55wt% (the remaining components are water);
[0107] (2) The composite bone filling material contains abundant bone morphogenetic protein BMP-2 and other osteogenic active factors and has high osteoinductivity;
[0108] (3) The inorganic phase of the composite bone filling material is clustered or spherical hydroxyapatite with a diameter of about 1 μm. A single clustered hydroxyapatite is composed of nano-scale flake hydroxyapatite, which has a larger specific surface area and higher bioavailability;
[0109] (4) The composite bone filling material is injectable, has good plasticity and is easy to operate;
[0110] (5) The composite bone filling material can be used for the rapid repair of oral and maxillofacial bone defects and can be biodegraded within 3 months, which is consistent with the bone formation time.
[0111] The schematic diagram of the mineralized decalcified cancellous bone filling material product prepared in step (ii) of the present invention is as follows Figure 1 shown.
[0112] Experimental Example 1: Comparison of the effects of different pretreatment methods on cancellous bone decalcification efficiency
[0113] According to the preparation method of Example 1, decalcification was performed with a 10 wt % EDTA solution, samples were taken at the time points in the table below, and after washing with purified water, the calcium content was determined according to the method of "GB / T 9695.13-2009 Determination of Calcium Content in Meat and Meat Products". The results are shown in Table 1:
[0114] Table 1 Effect of pretreatment methods on cancellous bone decalcification efficiency (calcium content%)
[0115]
[0116] As can be seen from Table 1, cancellous bones of different particle sizes have corresponding effects on the decalcification efficiency. In particular, the pretreatment method for preparing bone powder adopted in the present invention allows the decalcification time of cancellous bones to be only 4 hours, greatly reducing the time cost and the risk of microbial contamination.
[0117] Experimental Example 2: Comparison of the effects of different decalcification methods on the bioactivity of bone filling materials.
[0118] Traditional decalcification methods are mostly 0.6M hydrochloric acid treatment for 24 to 72 hours, which has a great impact on the active components of cancellous bone. Referring to the preparation method of Example 1, cancellous bone powder samples under different decalcification methods were prepared according to the conditions in Table 2, and each group of samples was extracted with 4M guanidine hydrochloride / Tris-HCl solution, and guanidine hydrochloride was removed by dialysis to make its concentration lower than 0.06M. The BMP-2 content in the sample was quantitatively detected by enzyme-linked immunosorbent assay (ELISA) kit; differential scanning calorimetry (DSC) was used to quantitatively detect the denaturation temperature of the sample. The results are shown in Table 2 below:
[0119] Table 2 Effects of decalcification methods on the biological activity and structure of cancellous bone
[0120]
[0121]
[0122] As shown in Table 2, as calcium and phosphate salts dissolve in the early stage of decalcification, BMP-2 factor is released, and the measured content increases. However, after calcium is completely removed, the BMP-2 content gradually decreases as the EDTA treatment time is prolonged, while the BMP-2 content has been significantly reduced after only 1h of hydrochloric acid decalcification, indicating that the decalcification of cancellous bone of the present invention is mild and short in time, and can effectively retain the BMPs protein required for bone formation. At the same time, the material denaturation temperature gradually decreases with the increase of the treatment time, indicating that the longer the treatment time, the more serious the damage to the material structure, further proving that the short treatment time of the decalcification process of the present invention is conducive to maintaining the biological activity and structure of the material.
[0123] Experimental Example 3: Effects of different mineralization processes on the formation of inorganic phase.
[0124] The traditional mineralization method is to immerse in simulated body fluid SBF, but collagen lacks mineralization nucleation sites, and the mineralization time is long and unstable. Referring to the preparation method of Example 1, the decalcified cancellous bone was treated with the different mineralization processes listed in Table 3, and samples were taken at the time points in the table below. After washing with purified water, the inorganic phase content was determined according to the ignition residue test method of 0841 of the four general rules of the Chinese Pharmacopoeia (2020 edition). The results are shown in Table 3. At the same time, the mineralization of each parallel sample of the three groups of samples after mineralization for 3 days was checked visually, and the results are shown in Table 4.
[0125] Table 3 Effect of mineralization mode on cancellous bone mineralization degree (inorganic phase content%)
[0126]
[0127]
[0128] Table 4. Mineralization of parallel samples in each mineralization mode group after 3 days of mineralization (×: not mineralized; √: mineralized)
[0129]
[0130] It can be seen from Tables 3 and 4 that traditional SBF immersion is not suitable for decalcified bone materials, and the mineralization efficiency is extremely low; when simply immersed in the patented mineralizing solution, some samples can be successfully mineralized to form a hydroxyapatite coating, but some samples cannot be mineralized, the mineralization success rate is low, and the process is unstable; while using the combined treatment method of phosphorylation + immersion in the patented mineralizing solution, all samples can be successfully mineralized, and the mineralization treatment has good stability and high efficiency, meeting the needs of industrial production.
[0131] Experimental Example 4
[0132] The performance test of the mineralized decalcified cancellous bone material prepared in step (ii) of the embodiment of the present invention was carried out. Taking the sample prepared in step (ii) of Example 1 as an example (the samples prepared in the other embodiments were not much different), the scanning electron microscope (SEM) showed that the surface of the decalcified cancellous bone before mineralization was relatively smooth and lacked an inorganic phase coating. After mineralization, a nanoscale inorganic phase coating was formed on the surface of the decalcified cancellous bone, which was in the form of clusters ( Figure 2 ), with a diameter of about 1 μm. After magnification, it can be seen that a single cluster of hydroxyapatite is composed of multiple nanoscale flake hydroxyapatite ( Figure 3 ), with a larger specific surface area and higher bioavailability. X-ray diffraction analysis results show that the inorganic phase coating is composed of hydroxyapatite ( Figure 4 ).
[0133] Experimental Example 5
[0134] A rabbit mandibular defect model was selected, with a size of 10 mm in diameter and 4 mm in depth. Bio-Oss was used as a control. After 8 weeks after surgery, it was found that both the product (the mineralized decalcified cancellous bone sample obtained in step (ii) of Example 1 was used as an example, and the samples of other examples were similar) and the control Bio-Oss had material residues ( Figure 5 ), X-rays showed that the edges of the modeling areas in the two groups were blurred, new bone formation was obvious, and they were connected into pieces, with no significant difference ( Figure 6 ), indicating that this product has good bone formation performance. After 12 weeks of surgery, it was found that the control product still had obvious material residues, while this product had no residues, indicating that this product has good biodegradability ( Figure 7 ).
[0135] Experimental Example 6
[0136] (1) Self-assembly process of thermosensitive cancellous bone hydrogel at 37°C
[0137] The thermosensitive cancellous bone hydrogel was prepared according to step (iii) of Example 1, and its self-assembly process was observed. Figure 8 As shown. It can be seen that at room temperature, the cancellous bone hydrogel is in a viscous liquid state and can flow down the wall when inverted ( Figure 8 Middle left), after being placed at 37°C, self-assembly and cross-linking can occur, transforming from liquid to solid and existing stably ( Figure 8 (2) Effect of the concentration of thermosensitive cancellous bone hydrogel on the self-assembly and cross-linking of the material
[0138] According to the method of Example 1, different concentrations of thermosensitive cancellous bone hydrogel were prepared, 1 mL was taken into a 1.5 mL centrifuge tube, and incubated in a 37°C water bath for 5 minutes. After the incubation, the centrifuge tube was inverted to observe whether it flowed down the wall. The results are shown in Table 5 below:
[0139] Table 5 Effect of thermosensitive cancellous bone hydrogel concentration on material self-assembly and cross-linking.
[0140] Gel concentration (%) Room temperature properties Incubate at 37°C for 5 min 1.0 Viscous liquid Can self-assemble, cannot flow down the wall, can exist stably 0.8 Thick liquid Can self-assemble, cannot flow down the wall, can exist stably 0.4 Thick liquid Can self-assemble, cannot flow down the wall, can exist stably 0.2 Non-viscous liquid Can self-assemble, cannot flow down the wall, relatively fragile 0.1 Non-viscous liquid No self-assembly
[0141] It can be seen from Table 5 that when the concentration of the thermosensitive cancellous bone hydrogel is lower than 0.4wt%, it cannot exist stably after self-assembly, but when it is higher than 0.8wt%, the viscosity is too high to be conducive to sufficient mixing with mineralized decalcified cancellous bone. Therefore, the 0.4% to 0.8wt% concentration hydrogel described in the present invention can have the characteristics of both sufficient mixing and stable existence.
[0142] (3) Effect of thermosensitive cancellous bone hydrogel concentration on the self-assembly cross-linking time of the material
[0143] According to the method of Example 1, different concentrations of hydrogel were prepared and added to a 96-well plate (100 μL / well) and placed in a microplate reader preheated to 37°C. The absorbance at 405 nm was measured every 1 minute for 15 minutes. The standardized absorbance NA was calculated (A is the absorbance at a given time, A0 is the initial absorbance, A max is the maximum absorbance), and draw a curve.
[0144]
[0145] According to the fitting curve, the half gel time (t 1 / 2 ), gelation rate (S) and lag time (t flag ), the results are shown in Table 6 and Fig. 9 :
[0146] ① Half gel time (t 1 / 2 ) is defined as the time when the absorbance reaches 50%;
[0147] ② The gelation rate (S) is defined as the maximum slope of the linear region of the gelation curve;
[0148] ③ Lag time (t flag ) is defined as the intercept of the linear region of the gel curve when the absorbance is 0%.
[0149] Table 6 Effect of thermosensitive cancellous bone hydrogel concentration on the self-assembly cross-linking time of the material.
[0150] Gel concentration (%) <![CDATA[Half gel time (t 1 / 2 )]]> Gel rate (S) <![CDATA[Lag time (t flag )]]> 0.8 2.21 0.37 1.15 0.4 3.89 0.30 2.49 0.2 5.69 0.21 3.86
[0151] From Table 6 and Fig. 9 It can be seen that the higher the concentration of the thermosensitive cancellous bone hydrogel, the shorter the self-assembly cross-linking time. The 0.4% to 0.8wt% concentration hydrogel of the present invention can complete self-assembly cross-linking within 5 minutes, which is convenient for clinical use and has strong operability.
[0152] (4) Effect of ionic strength of thermosensitive cancellous bone hydrogel on self-assembly and cross-linking of materials
[0153] According to the method of Example 1, hydrogels with different ionic strengths were prepared, 1 mL was taken into a 2 mL centrifuge tube, and incubated in a 37°C water bath for 5 minutes. After the incubation, the centrifuge tube was inverted to observe whether it flowed down the wall. The results are as follows Fig.10 :
[0154] Depend on Fig.10 It can be seen that the ionic strength can be self-assembled and cross-linked within 5 minutes in the range of 0.5-1.5×PBS, and it can exist stably without flowing down the wall. Considering that the ionic strength under human physiological conditions is about 1×PBS, the thermosensitive cancellous bone hydrogel of the present invention can stably self-assemble and cross-link under the ionic strength under physiological conditions.
[0155] (5) Scanning electron microscopy (SEM) showed that the thermosensitive cancellous bone hydrogel exhibited a three-dimensional reticular scaffold structure ( Fig.11 ), which is conducive to the growth of osteoblasts and capillaries.
[0156] (6) Ion release of morphologically plastic biomimetic mineralized composite bone filling materials
[0157] The decalcified cancellous bone and the composite bone filling material of the present invention were placed in physiological saline and incubated under shaking at 37°C. The supernatant was collected daily and the calcium ions in the supernatant were detected by electrochemical method. Fig.12 ) and phosphate ions ( Fig.13 )content.
[0158] (7) A Beagle dog alveolar bone defect model with a size of approximately 8 mm wide × 10 mm long × 10 mm deep was selected, and decalcified cancellous bone was used as a control. Implantation is sufficient. This product can stay smoothly and stably in the tooth extraction socket and will not be washed away by blood, while the control product will spill during the implantation process, and there is no need to use it in conjunction with an oral repair membrane ( Fig.14 ). X-rays taken 12 weeks after surgery showed that the defect areas of both groups showed obvious high-density shadow particles of filling material, the defect boundary line disappeared, new bone formation increased significantly, and a bone marrow cavity was formed. The bone formation effect of this product was significantly better than that of the control product ( Fig.15 ), indicating that this product has good osteogenic properties.
Claims
1. A method for preparing a morphologically plastic bionic mineralized composite bone filling material, characterized in that: The following steps are involved:
1. Preparation of decalcified cancellous bone (1) The cancellous bone is crushed into bone powder with a particle size of 0.3 to 0.8 mm, and then added to an EDTA solution at a solid-liquid ratio of 1:5 to 1:30 w / v, and decalcified at room temperature for 4 to 16 hours under shaking; (2) adding the cancellous bone treated in step (1) to a peracetic acid solution at a solid-liquid ratio of 1:4 w / v, and shaking at room temperature for 2 hours; (3) adding the cancellous bone treated in step (2) to isopropanol at a solid-liquid ratio of 1:5 to 1:10 w / v, and degreasing by shaking at room temperature for 24 hours; (4) adding the cancellous bone treated in step (3) to a 1-4 wt% sodium deoxycholate solution at a solid-liquid ratio of 1:5-1:10 w / v, and shaking at room temperature to decellularize for 8-24 hours to prepare decalcified cancellous bone; 2. Preparation of mineralized decalcified cancellous bone (5) adding the decalcified cancellous bone obtained in step (4) to a 2-3 wt % sodium trimetaphosphate solution at a material-liquid ratio of 1:5-1:10 w / v, shaking at room temperature for 1 hour, and performing phosphorylation treatment; (6) immersing the phosphorylated decalcified cancellous bone in a mineralizing solution at a material-liquid ratio of 1:200 to 1:500 w / v, and performing biomimetic mineralization at 37° C. for 1 to 5 days with shaking, wherein the mineralizing solution comprises: 100 to 160 mM sodium chloride, 2 to 4 mM dipotassium hydrogen phosphate, 3 to 5 mM magnesium chloride, 35 to 40 mM 4-hydroxyethylpiperazineethanesulfonic acid, 15 to 22 mM sodium bicarbonate, 6 to 9 mM calcium chloride, and a pH value of 6.5 to 7.0, to prepare mineralized decalcified cancellous bone; (III) Preparation of thermosensitive cancellous bone hydrogel (7) taking the decalcified cancellous bone obtained in step (4), adding it to a 0.1 wt % porcine pepsin solution at a solid-liquid ratio of 1:100 w / v, and stirring at 4° C. for 24 to 48 hours; (8) adjusting the pH and ionic strength of the product obtained in step (7) to 7.2-7.4 and the ionic strength to 0.5-1.5×PBS, and then adding 1×PBS to adjust the concentration of the hydrogel solution to 0.4-0.8 wt %; (IV) Preparation of biomimetic mineralized composite bone filling materials (9) Take the mineralized decalcified cancellous bone obtained in step (6), add it to the hydrogel solution obtained in step (8) at a material-liquid ratio of 1 to 3:1 w / v, and stir at 4° C. for 24 hours to obtain a biomimetic mineralized composite bone filling material.
2. The preparation method according to claim 1, characterized in that: The concentration of the EDTA solution in step (1) is 10 wt %; preferably, the pH value of the EDTA solution is 7.
4.
3. The preparation method according to claim 1, characterized in that: The concentration of the peracetic acid solution in step (2) is 0.3 wt %.
4. The preparation method according to claim 1, characterized in that: The pH of the sodium deoxycholate solution in step (4) is 8; preferably, the pH of the sodium trimetaphosphate solution in step (5) is 10.
5. The preparation method according to claim 1, characterized in that: In step (6), during the oscillating biomimetic mineralization process, the mineralization solution is replaced every 24 hours.
6. The preparation method according to any one of claims 1 to 5, characterized in that: In steps (1) to (6), the cancellous bone after each treatment is cleaned. The cleaning steps are as follows: pour the treated cancellous bone into purified water at a solid-liquid ratio of 1:10 to 1:20 w / v, shake and clean at room temperature for 1 hour, and change the liquid every 5 minutes.
7. The preparation method according to claim 1, characterized in that: The pH of the porcine pepsin solution in step (7) is 2-3.
8. The preparation method according to claim 1, characterized in that: The operation of adjusting the pH and ionic strength in step (8) is as follows: 0.1 M sodium hydroxide is added dropwise to the product treated in step (7) at 4° C. with stirring until the pH range is 7.2 to 7.4; then 10×PBS buffer is slowly added to the product to adjust the ionic strength of the solution to 0.5 to 1.5×PBS.
9. The biomimetic mineralized composite bone filling material obtained by the preparation method according to any one of claims 1 to 8, characterized in that: The organic phase in the bionic mineralized composite bone filling material accounts for 15-25wt%, and the inorganic phase accounts for 35-55wt%.
10. Use of the biomimetic mineralized composite bone filling material prepared by the method according to any one of claims 1 to 8 or according to claim 9 as a filling material for oral and maxillofacial bone defects.
Citation Information
Patent Citations
Method for preparing absorbable and antibacterial guided tissue regeneration membrane for bone-like structure
CN104436318A
Temperature-sensitive adhesive decalcified-bone composite tissue engineering support and preparation method thereof
CN110368527A
Acellular bone matrix hydrogel with reserved natural hydroxyapatite and preparation method of acellular bone matrix hydrogel
CN111905146A
Method for preparing porous bioceramic bone substitute materials
US20050179172A1
